NVIV News and Press, InVivo Therapeutics Holdings Corp. From 07/16/19

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a manuscript in the peer-reviewed journal Spinal Cord describing its CONTEMPO registry study data. The CONTEMPO registry study, part of the Company’s IDE submission for the Neuro-Spinal Scaffold&#...

InVivo Therapeutics Holdings (NASDAQ: NVIV ) has postponed its 2019 annual meeting of stockholders, as the company was short of the quorum. More news on: InVivo Therapeutics Holdings Corp., Healthcare stocks news, Read more ...

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has postponed its 2019 annual meeting of stockholders. The annual meeting, which was originally scheduled for June 11, 2019, had been adjourned until July 11, 2019 at 8:00 am Eastern Time. Less than a majority of the ...

- Scheduled to Reconvene on July 2, 2019 - - Company urgently encourages stockholders to vote - InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that its 2019 Annual Meeting of Stockholders, scheduled for June 11, 2019, was convened and adjourned without any bu...

InVivo Therapeutics Holdings ( NVIV -1.3% ) announces the enrollment of the first two participants in the INSPIRE 2.0 Study evaluating its Neuro-Spinal Scaffold in patients with complete thoracic spinal cord injury. More news on: InVivo Therapeutics Holdings Corp., Healthcare stocks ...

InVivo Therapeutics Holdings Corp. (NVIV) today announced that the first two patients have been enrolled into The INSPIRE 2.0 Study ( In Vivo Study of Probable Benefit of the Neuro- Spi nal Scaffold™ for Safety and Neurologic Re covery in Subjects with Complete Thoracic AIS A S...

Thinly traded nano cap InVivo Therapeutics Holdings (NASDAQ: NVIV ) is up up  2%  premarket on light volume on the heels of 12-month data from the INSPIRE study of its Neuro-Spinal Scaffold in patients with complete thoracic spinal cord injury. The results were presented at the...

- E-poster Presented at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting - InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) (“InVivo” or the “Company”) today announced the presentation of the twelve-month results fr...

InVivo Therapeutics (NASDAQ: NVIV ): FY Non-GAAP EPS of -$2.25; GAAP EPS of -$4.69 beats by $6.89. Cash and cash equivalents of $16.66M Press Release More news on: InVivo Therapeutics Holdings Corp., Earnings news and commentary, Healthcare stocks news, ,

Gainers:  Helios and Matheson Analytics (NASDAQ: HMNY ) +49% . Cool Holdings (NASDAQ: AWSM ) +20% . Fortress Biotech (NASDAQ: FBIO ) +19% . Azure Power Global (NYSE: AZRE ) +18% . MYnd Analytics (NASDAQ: MYND ) +18% . Versum Materials (NYSE: VSM ) +16% . Reebonz Holding ( RBZ ) ...